Stocks in play: Acasti Pharma Inc.
Announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma will be presenting at the 32nd Annual Oppenheimer Healthcare conference being held virtually March 15-17. Acasti Pharma Inc. shares V.ACST are trading down $0.01 at $1.29.
Read:
So far, Technology is Driving Vegan-Friendly Food Innovation in 2022
Record $5 Billion Invested into Global Sustainable Protein Companies in 2021
Alternatives Continue to Compete with Meat in the Market for Protein Dominance
Rising Demand for Textured Vegetable Protein (TVP) Bolstering Vegan-Friendly Stock Values
Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer